Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0010732 | HP:0010732 | Nodular changes affecting the eyelids | 0 | ABCA1 CL E G H | 19 | 29 | ORPHA:425 | Apolipoprotein A-I deficiency | | | | 191 | | |
HP:0010732 | HP:0010732 | Nodular changes affecting the eyelids | 0 | ABCG8 CL E G H | 64241 | 13887 | OMIM:210250 | Sitosterolemia 1 | | | | 76 | | |
HP:0010732 | HP:0010732 | Nodular changes affecting the eyelids | 0 | APOA1 CL E G H | 335 | 600 | ORPHA:425 | Apolipoprotein A-I deficiency | | | | 40 | | |
HP:0010732 | HP:0010732 | Nodular changes affecting the eyelids | 0 | APOA2 CL E G H | 336 | 601 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 9 | | |
HP:0010732 | HP:0010732 | Nodular changes affecting the eyelids | 0 | APOB CL E G H | 338 | 603 | OMIM:144010 | Hypercholesterolemia, familial, 2 | | | | 356 | | |
HP:0010732 | HP:0010732 | Nodular changes affecting the eyelids | 0 | APOE CL E G H | 348 | 613 | ORPHA:412 | Dysbetalipoproteinemia | | | | 39 | | |
HP:0010732 | HP:0010732 | Nodular changes affecting the eyelids | 0 | CYP27A1 CL E G H | 1593 | 2605 | OMIM:213700 | Cerebrotendinous xanthomatosis | | | | 114 | | |
HP:0010732 | HP:0010732 | Nodular changes affecting the eyelids | 0 | EPHX2 CL E G H | 2053 | 3402 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 1 | | |
HP:0010732 | HP:0010732 | Nodular changes affecting the eyelids | 0 | G6PC1 CL E G H | 2538 | 4056 | OMIM:232200 | Glycogen storage disease ia | | | | | | |
HP:0010732 | HP:0010732 | Nodular changes affecting the eyelids | 0 | GHR CL E G H | 2690 | 4263 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 98 | | |
HP:0010732 | HP:0010732 | Nodular changes affecting the eyelids | 0 | LDLR CL E G H | 3949 | 6547 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 2157 | | |
HP:0010732 | HP:0010732 | Nodular changes affecting the eyelids | 0 | LPL CL E G H | 4023 | 6677 | OMIM:144250 | Hyperlipidemia, familial combined, 3 | | | | 106 | | |
HP:0010732 | HP:0010732 | Nodular changes affecting the eyelids | 0 | PCSK9 CL E G H | 255738 | 20001 | OMIM:603776 | HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, 3; HCHOLA3 | | | | 178 | | |
HP:0010732 | HP:0010732 | Nodular changes affecting the eyelids | 0 | PDE11A CL E G H | 50940 | 8773 | ORPHA:1359 | Carney complex | | | | 13 | | |
HP:0010732 | HP:0010732 | Nodular changes affecting the eyelids | 0 | PPP1R17 CL E G H | 10842 | 16973 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 2 | | |
HP:0010732 | HP:0010732 | Nodular changes affecting the eyelids | 0 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:1359 | Carney complex | | | | 134 | | |
HP:0010732 | HP:0010732 | Nodular changes affecting the eyelids | 0 | SLC37A4 CL E G H | 2542 | 4061 | ORPHA:79259 | Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib | | | | 110 | | |
HP:0010732 | HP:0010732 | Nodular changes affecting the eyelids | 0 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:232220 | Glycogen storage disease ib | | | | 110 | | |
HP:0010732 | HP:0010732 | Nodular changes affecting the eyelids | 0 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:232240 | GLYCOGEN STORAGE DISEASE Ic | | | | 110 | | |
HP:0010732 | HP:0010732 | Nodular changes affecting the eyelids | 0 | SPRED1 CL E G H | 161742 | 20249 | ORPHA:137605 | Legius syndrome | | | | 136 | | |
HP:0010732 | HP:0010732 | Nodular changes affecting the eyelids | 0 | TTPA CL E G H | 7274 | 12404 | OMIM:277460 | VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF | | | | 62 | | |
HP:0010732 | HP:0010606 | Hordeolum | 1 | CL E G H | | | | | | | | | | |
HP:0010732 | HP:0010604 | Cyst of the eyelid | 1 | CL E G H | | | | | | | | | | |
HP:0010732 | HP:0001114 | Xanthelasma | 1 | ABCA1 CL E G H | 19 | 29 | ORPHA:425 | Apolipoprotein A-I deficiency | | | | 191 | | |
HP:0010732 | HP:0001114 | Xanthelasma | 1 | ABCG8 CL E G H | 64241 | 13887 | OMIM:210250 | Sitosterolemia 1 | | | | 76 | | |
HP:0010732 | HP:0001114 | Xanthelasma | 1 | APOA1 CL E G H | 335 | 600 | ORPHA:425 | Apolipoprotein A-I deficiency | | | | 40 | | |
HP:0010732 | HP:0001114 | Xanthelasma | 1 | APOA2 CL E G H | 336 | 601 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 9 | | |
HP:0010732 | HP:0001114 | Xanthelasma | 1 | APOB CL E G H | 338 | 603 | OMIM:144010 | Hypercholesterolemia, familial, 2 | . | | | 356 | | |
HP:0010732 | HP:0001114 | Xanthelasma | 1 | APOE CL E G H | 348 | 613 | ORPHA:412 | Dysbetalipoproteinemia | HP:0040282 - Frequent | | | 39 | | |
HP:0010732 | HP:0001114 | Xanthelasma | 1 | CYP27A1 CL E G H | 1593 | 2605 | OMIM:213700 | Cerebrotendinous xanthomatosis | | | | 114 | | |
HP:0010732 | HP:0001114 | Xanthelasma | 1 | EPHX2 CL E G H | 2053 | 3402 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 1 | | |
HP:0010732 | HP:0001114 | Xanthelasma | 1 | G6PC1 CL E G H | 2538 | 4056 | OMIM:232200 | Glycogen storage disease ia | . | | | | | |
HP:0010732 | HP:0001114 | Xanthelasma | 1 | GHR CL E G H | 2690 | 4263 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 98 | | |
HP:0010732 | HP:0001114 | Xanthelasma | 1 | LDLR CL E G H | 3949 | 6547 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 2157 | | |
HP:0010732 | HP:0001114 | Xanthelasma | 1 | LPL CL E G H | 4023 | 6677 | OMIM:144250 | Hyperlipidemia, familial combined, 3 | HP:0040283 - Occasional | | | 106 | | |
HP:0010732 | HP:0001114 | Xanthelasma | 1 | PCSK9 CL E G H | 255738 | 20001 | OMIM:603776 | HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, 3; HCHOLA3 | | | | 178 | | |
HP:0010732 | HP:0001114 | Xanthelasma | 1 | PPP1R17 CL E G H | 10842 | 16973 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 2 | | |
HP:0010732 | HP:0001114 | Xanthelasma | 1 | SLC37A4 CL E G H | 2542 | 4061 | ORPHA:79259 | Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib | HP:0040283 - Occasional | | | 110 | | |
HP:0010732 | HP:0001114 | Xanthelasma | 1 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:232220 | Glycogen storage disease ib | . | | | 110 | | |
HP:0010732 | HP:0001114 | Xanthelasma | 1 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:232240 | GLYCOGEN STORAGE DISEASE Ic | . | | | 110 | | |
HP:0010732 | HP:0001114 | Xanthelasma | 1 | SPRED1 CL E G H | 161742 | 20249 | ORPHA:137605 | Legius syndrome | | | | 136 | | |
HP:0010732 | HP:0001114 | Xanthelasma | 1 | TTPA CL E G H | 7274 | 12404 | OMIM:277460 | VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF | . | | | 62 | | |
HP:0010732 | HP:0010605 | Chalazion | 2 | CL E G H | | | | | | | | | | |
HP:0010732 | HP:0010608 | Hordeolum internum | 2 | CL E G H | | | | | | | | | | |
HP:0010732 | HP:0010607 | Hordeolum externum | 2 | CL E G H | | | | | | | | | | |